Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
221.25
-1.51 (-0.68%)
Oct 30, 2026, 1:48 PM EDT - Market open
Moderna Employees
Moderna had 4,700 employees as of December 31, 2025. The number of employees decreased by 1,100 or 18.97% compared to the previous year. That makes Moderna the 5,944th largest employer in the world and 1,183rd in the United States.
Employees
4,700
Change (1Y)
-1,100
Growth (1Y)
-18.97%
Revenue / Employee
$474,043
Profits / Employee
-$670,426
Market Cap
88.33B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | -1,100 | -18.97% |
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,343 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Vertex Pharmaceuticals | 6,400 |
| Genmab | 3,119 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
MRNA News
- 1 day ago - Moderna's CEO told The Wall Street Journal that his cancer vaccine's data will get better with time, and that no one can easily copy the company's work - WSJ
- 3 days ago - Moderna falls -7.7% - TheFly
- 3 days ago - Moderna Stock (MRNA) Falls 3% as Analysts Question $80 Billion Valuation Despite CEO’s Defense of Cancer Vaccine - TipRanks
- 3 days ago - Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot. - Barrons
- 3 days ago - Moderna downgraded to Market Perform from Outperform at William Blair - TheFly
- 3 days ago - Moderna down 3% to $192.90 after William Blair downgrade - TheFly
- 3 days ago - Moderna's Rally May Have Run Out of Steam. Here's What to Watch Next - Investopedia
- 4 days ago - The excitement around Moderna's cancer vaccine is cooling. Here's why. - Market Watch